|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Scarab Genomics Introduces ScarabXpress(TM) T7lac, a unique E. coli Expression Strain
9/29/2009 9:46:15 AM
MADISON, Wis.--(BUSINESS WIRE)--ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter. MDS™42 is a K-12 strain with a 15% genome reduction to remove non-essential genes, sequences for recombinogenic and mobile DNA, and cryptic virulence genes, while preserving robust growth and protein production. Scarab has removed Insertion sequence (IS) elements, which are a prevalent, but frequently overlooked, problem that contributes to clonal instability. In addition, Clean Genome® strains lack prophage, which can be stress-activated and cause premature lysis and failed runs during fermentation. Genome reduction optimizes Clean Genome E. coli for recombinant DNA and protein production, providing enhanced genetic stability and improved metabolic efficiency, and making them the strains of choice for applications ranging from routine cloning to manufacturing biotherapeutics.
|
|
|
|
|
|
|
|
|
|
|